ReAlta Life Sciences
VA - NorfolkBiotechnology
Focus: ReAlta Life Sciences is a biotechnology company focused on developing complement and inflammation inhibition drug products for immunological indications. The company is in early-stage development with a single lead program (RLS-0071) being evaluated across multiple disease indications.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About ReAlta Life Sciences
AI assessmentNot HiringNo open roles listed right now. Follow ReAlta Life Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
RLS-0071 10 mg/kg
Acute Lung InjuryClinical Trials (1)
NCT04574869A Study of RLS-0071 in Patients With Acute Lung Injury Due to COVID-19 Pneumonia in Early Respiratory Failure
Phase 1Help build intelligence for ReAlta Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.